𝐌𝐘𝐋𝐈𝐕𝐄 𝟐𝟎𝟐𝟓 — 𝐌𝐨𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧 & 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐭𝐡𝐞 𝐇𝐞𝐚𝐫𝐭 𝐨𝐟 𝐀𝐒𝐄𝐀𝐍 🫀

The 21st Malaysian Cardiovascular Interventional Symposium (MYLIVE 2025) has officially begun at the Kuala Lumpur Convention Centre (11–13 Sept), bringing together leading cardiologists, healthcare professionals, and global experts in interventional cardiology.

This year’s highlights include:
Live case transmissions from Hospital Sultan Idris Shah Serdang
Cutting-edge sessions on complex PCI, STEMI, bifurcation & TAVI
The latest advances in imaging, physiology & structural heart interventions

As one of the official exhibitors, 𝗔𝘃𝗲𝗹𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 & 𝗕𝗶𝗼𝗯𝗮𝘆 𝟯𝟳°𝗖 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 are proud to contribute to this important platform. With cardiovascular disease being Malaysia’s No.1 cause of death, awareness and innovation are key to better prevention, treatment, and long-term management.

Through evidence-based supplements, patient-focused solutions, and strong partnerships, we are committed to supporting cardiovascular health in Malaysia and across ASEAN.